Drug Discovery Informatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mode (In-house, Outsourced), By Workflow (Discovery, Development), By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others), By Region and Competition, 2020-2030F
The Global Drug Discovery Informatics Market, valued at USD 3.48 Billion in 2024, is projected to experience a CAGR of 9.40% to reach USD 5.97 Billion by 2030. Drug discovery informatics involves the application of computational methods and analytical tools to manage, analyze, and interpret the extensive and varied data generated throughout the drug discovery process, thereby enhancing the efficiency of identifying and optimizing potential drug candidates. The market's growth is primarily driven by substantial investments in pharmaceutical research and development, a necessity to process the increasing volume and complexity of scientific data, and the continuous pressure to reduce drug development timelines and associated costs.
Key Market Drivers
The rapid proliferation of big data in drug discovery is a core driver accelerating the growth of the informatics market. The escalating volume and complexity of data generated from genomic sequencing, proteomics, and advanced experimental assays require sophisticated computational tools for effective data management, analysis, and interpretation. This expanding data ecosystem is driving strong demand for informatics platforms capable of integrating diverse datasets and transforming them into actionable insights for identifying and prioritising potential drug candidates. Reflecting the scale of this data generation, the report Genomics Market Size, Trends and Tailored Solutions for Personalized Medicine stated that the global genomics market was valued at USD 38.52 billion in 2024, underscoring the magnitude of information being produced and the corresponding need for high-performance informatics solutions to accelerate early-stage drug development.
Key Market Challenges
The complexity of data integration and persistent interoperability challenges across fragmented platforms and heterogeneous data sources pose a significant constraint on the growth of the Global Drug Discovery Informatics Market. The pharmaceutical industry produces vast volumes of diverse data across multiple workflows, including genomics, proteomics, and clinical trials. However, these datasets frequently remain siloed within disconnected systems, creating substantial barriers to standardisation, consolidation, and holistic analysis. This lack of seamless integration limits the ability to establish a unified and comprehensive research view, which is essential for accelerating drug candidate identification and optimisation.
Key Market Trends
The adoption of cloud-native informatics platforms represents a significant trend in the global drug discovery informatics market, moving away from on-premise infrastructure to scalable, accessible cloud-based solutions. This shift provides enhanced flexibility and computational power for managing and analyzing the vast datasets generated in drug discovery. According to a Pistoia Alliance survey published in September 2025, 80% of life sciences labs now utilize cloud data platforms, marking an increase from 70% in 2023. This growth underscores the industry’s recognition of cloud benefits, including improved collaboration and reduced IT overheads.
Key Market Players
In this report, the Global Drug Discovery Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Drug Discovery Informatics Market.
Available Customizations:
Global Drug Discovery Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The rapid proliferation of big data in drug discovery is a core driver accelerating the growth of the informatics market. The escalating volume and complexity of data generated from genomic sequencing, proteomics, and advanced experimental assays require sophisticated computational tools for effective data management, analysis, and interpretation. This expanding data ecosystem is driving strong demand for informatics platforms capable of integrating diverse datasets and transforming them into actionable insights for identifying and prioritising potential drug candidates. Reflecting the scale of this data generation, the report Genomics Market Size, Trends and Tailored Solutions for Personalized Medicine stated that the global genomics market was valued at USD 38.52 billion in 2024, underscoring the magnitude of information being produced and the corresponding need for high-performance informatics solutions to accelerate early-stage drug development.
Key Market Challenges
The complexity of data integration and persistent interoperability challenges across fragmented platforms and heterogeneous data sources pose a significant constraint on the growth of the Global Drug Discovery Informatics Market. The pharmaceutical industry produces vast volumes of diverse data across multiple workflows, including genomics, proteomics, and clinical trials. However, these datasets frequently remain siloed within disconnected systems, creating substantial barriers to standardisation, consolidation, and holistic analysis. This lack of seamless integration limits the ability to establish a unified and comprehensive research view, which is essential for accelerating drug candidate identification and optimisation.
Key Market Trends
The adoption of cloud-native informatics platforms represents a significant trend in the global drug discovery informatics market, moving away from on-premise infrastructure to scalable, accessible cloud-based solutions. This shift provides enhanced flexibility and computational power for managing and analyzing the vast datasets generated in drug discovery. According to a Pistoia Alliance survey published in September 2025, 80% of life sciences labs now utilize cloud data platforms, marking an increase from 70% in 2023. This growth underscores the industry’s recognition of cloud benefits, including improved collaboration and reduced IT overheads.
Key Market Players
- Dassault Systemes SE
- IBM Corporation
- Infosys Ltd.
- Schr?dinger Inc.
- Jubilant Life Sciences NV
- Aragen Lifescience Ltd.
- Charles River Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Clarivate Analytics LLC
- PerkinElmer Inc.
In this report, the Global Drug Discovery Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Drug Discovery Informatics Market, By Mode:
- In-house
- Outsourced
- Drug Discovery Informatics Market, By Workflow:
- Discovery
- Development
- Drug Discovery Informatics Market, By Services:
- Sequence Analysis Platforms
- Molecular Modelling
- Docking
- Clinical Trial Data Management
- Others
- Drug Discovery Informatics Market, By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROS)
- Others
- Drug Discovery Informatics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Drug Discovery Informatics Market.
Available Customizations:
Global Drug Discovery Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Mode (In-house, Outsourced)
5.2.2. By Workflow (Discovery, Development)
5.2.3. By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others)
5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mode
6.2.2. By Workflow
6.2.3. By Services
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Discovery Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Mode
6.3.1.2.2. By Workflow
6.3.1.2.3. By Services
6.3.1.2.4. By End User
6.3.2. Canada Drug Discovery Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Mode
6.3.2.2.2. By Workflow
6.3.2.2.3. By Services
6.3.2.2.4. By End User
6.3.3. Mexico Drug Discovery Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Mode
6.3.3.2.2. By Workflow
6.3.3.2.3. By Services
6.3.3.2.4. By End User
7. EUROPE DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mode
7.2.2. By Workflow
7.2.3. By Services
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Discovery Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Mode
7.3.1.2.2. By Workflow
7.3.1.2.3. By Services
7.3.1.2.4. By End User
7.3.2. France Drug Discovery Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Mode
7.3.2.2.2. By Workflow
7.3.2.2.3. By Services
7.3.2.2.4. By End User
7.3.3. United Kingdom Drug Discovery Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Mode
7.3.3.2.2. By Workflow
7.3.3.2.3. By Services
7.3.3.2.4. By End User
7.3.4. Italy Drug Discovery Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Mode
7.3.4.2.2. By Workflow
7.3.4.2.3. By Services
7.3.4.2.4. By End User
7.3.5. Spain Drug Discovery Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Mode
7.3.5.2.2. By Workflow
7.3.5.2.3. By Services
7.3.5.2.4. By End User
8. ASIA PACIFIC DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mode
8.2.2. By Workflow
8.2.3. By Services
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Drug Discovery Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Mode
8.3.1.2.2. By Workflow
8.3.1.2.3. By Services
8.3.1.2.4. By End User
8.3.2. India Drug Discovery Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Mode
8.3.2.2.2. By Workflow
8.3.2.2.3. By Services
8.3.2.2.4. By End User
8.3.3. Japan Drug Discovery Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Mode
8.3.3.2.2. By Workflow
8.3.3.2.3. By Services
8.3.3.2.4. By End User
8.3.4. South Korea Drug Discovery Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Mode
8.3.4.2.2. By Workflow
8.3.4.2.3. By Services
8.3.4.2.4. By End User
8.3.5. Australia Drug Discovery Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Mode
8.3.5.2.2. By Workflow
8.3.5.2.3. By Services
8.3.5.2.4. By End User
9. MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Mode
9.2.2. By Workflow
9.2.3. By Services
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Drug Discovery Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Mode
9.3.1.2.2. By Workflow
9.3.1.2.3. By Services
9.3.1.2.4. By End User
9.3.2. UAE Drug Discovery Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Mode
9.3.2.2.2. By Workflow
9.3.2.2.3. By Services
9.3.2.2.4. By End User
9.3.3. South Africa Drug Discovery Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Mode
9.3.3.2.2. By Workflow
9.3.3.2.3. By Services
9.3.3.2.4. By End User
10. SOUTH AMERICA DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Mode
10.2.2. By Workflow
10.2.3. By Services
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Drug Discovery Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Mode
10.3.1.2.2. By Workflow
10.3.1.2.3. By Services
10.3.1.2.4. By End User
10.3.2. Colombia Drug Discovery Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Mode
10.3.2.2.2. By Workflow
10.3.2.2.3. By Services
10.3.2.2.4. By End User
10.3.3. Argentina Drug Discovery Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Mode
10.3.3.2.2. By Workflow
10.3.3.2.3. By Services
10.3.3.2.4. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Dassault Systemes SE
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. IBM Corporation
15.3. Infosys Ltd.
15.4. Schr?dinger Inc.
15.5. Jubilant Life Sciences NV
15.6. Aragen Lifescience Ltd.
15.7. Charles River Laboratories Inc.
15.8. Thermo Fisher Scientific Inc.
15.9. Clarivate Analytics LLC
15.10. PerkinElmer Inc.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Mode (In-house, Outsourced)
5.2.2. By Workflow (Discovery, Development)
5.2.3. By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others)
5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mode
6.2.2. By Workflow
6.2.3. By Services
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Discovery Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Mode
6.3.1.2.2. By Workflow
6.3.1.2.3. By Services
6.3.1.2.4. By End User
6.3.2. Canada Drug Discovery Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Mode
6.3.2.2.2. By Workflow
6.3.2.2.3. By Services
6.3.2.2.4. By End User
6.3.3. Mexico Drug Discovery Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Mode
6.3.3.2.2. By Workflow
6.3.3.2.3. By Services
6.3.3.2.4. By End User
7. EUROPE DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mode
7.2.2. By Workflow
7.2.3. By Services
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Discovery Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Mode
7.3.1.2.2. By Workflow
7.3.1.2.3. By Services
7.3.1.2.4. By End User
7.3.2. France Drug Discovery Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Mode
7.3.2.2.2. By Workflow
7.3.2.2.3. By Services
7.3.2.2.4. By End User
7.3.3. United Kingdom Drug Discovery Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Mode
7.3.3.2.2. By Workflow
7.3.3.2.3. By Services
7.3.3.2.4. By End User
7.3.4. Italy Drug Discovery Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Mode
7.3.4.2.2. By Workflow
7.3.4.2.3. By Services
7.3.4.2.4. By End User
7.3.5. Spain Drug Discovery Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Mode
7.3.5.2.2. By Workflow
7.3.5.2.3. By Services
7.3.5.2.4. By End User
8. ASIA PACIFIC DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mode
8.2.2. By Workflow
8.2.3. By Services
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Drug Discovery Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Mode
8.3.1.2.2. By Workflow
8.3.1.2.3. By Services
8.3.1.2.4. By End User
8.3.2. India Drug Discovery Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Mode
8.3.2.2.2. By Workflow
8.3.2.2.3. By Services
8.3.2.2.4. By End User
8.3.3. Japan Drug Discovery Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Mode
8.3.3.2.2. By Workflow
8.3.3.2.3. By Services
8.3.3.2.4. By End User
8.3.4. South Korea Drug Discovery Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Mode
8.3.4.2.2. By Workflow
8.3.4.2.3. By Services
8.3.4.2.4. By End User
8.3.5. Australia Drug Discovery Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Mode
8.3.5.2.2. By Workflow
8.3.5.2.3. By Services
8.3.5.2.4. By End User
9. MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Mode
9.2.2. By Workflow
9.2.3. By Services
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Drug Discovery Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Mode
9.3.1.2.2. By Workflow
9.3.1.2.3. By Services
9.3.1.2.4. By End User
9.3.2. UAE Drug Discovery Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Mode
9.3.2.2.2. By Workflow
9.3.2.2.3. By Services
9.3.2.2.4. By End User
9.3.3. South Africa Drug Discovery Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Mode
9.3.3.2.2. By Workflow
9.3.3.2.3. By Services
9.3.3.2.4. By End User
10. SOUTH AMERICA DRUG DISCOVERY INFORMATICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Mode
10.2.2. By Workflow
10.2.3. By Services
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Drug Discovery Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Mode
10.3.1.2.2. By Workflow
10.3.1.2.3. By Services
10.3.1.2.4. By End User
10.3.2. Colombia Drug Discovery Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Mode
10.3.2.2.2. By Workflow
10.3.2.2.3. By Services
10.3.2.2.4. By End User
10.3.3. Argentina Drug Discovery Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Mode
10.3.3.2.2. By Workflow
10.3.3.2.3. By Services
10.3.3.2.4. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Dassault Systemes SE
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. IBM Corporation
15.3. Infosys Ltd.
15.4. Schr?dinger Inc.
15.5. Jubilant Life Sciences NV
15.6. Aragen Lifescience Ltd.
15.7. Charles River Laboratories Inc.
15.8. Thermo Fisher Scientific Inc.
15.9. Clarivate Analytics LLC
15.10. PerkinElmer Inc.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
